The Middle East & Africa aquaculture vaccines market is expected to grow from US$ 6.52 million in 2022 to US$ 12.82 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2022 to 2028.

Development of Novel Vaccines is Driving the Middle East & Africa Aquaculture Vaccines Market

In recent years, aquaculture has attained a major economic revolution. Advancements in science have paved new avenues in basic and applied research areas for developing and designing novel and effective vaccines and improving existing vaccines for various infectious diseases. Recent developments in vaccines and vaccinology are done to discover new vaccine candidates to combat fish pathogens, including mycotic and parasitic agents, for which vaccines are still lacking. Therefore, novel vaccine developments are expected to boost for Middle East & Africa aquaculture vaccines market during the forecast period.

Middle East & Africa Aquaculture Vaccines Market Overview

The Middle East & Africa aquaculture vaccines market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The market factors, such as rising consumption of seafood, growing government efforts, and rising infectious diseases among aquatic animals, are expected to boost the growth of aquaculture vaccines over the forecast period. The UAE is a net importer of seafood, and the country imports up to 90% of its consumed foods. In 2020, the country’s import of fish and seafood from the world was valued at US$637 million, while exports were valued at US$331 million. In the same year, India was the main fish and seafood supplier to the UAE, with 27.7% of the market share and imports valued at US$176.2 million. Thailand followed it with 9.8% and Vietnam with 7.8%. In 2020, the top commodities imported into the country were frozen shrimps and prawns, prepared/preserved tunas, fresh/chilled Atlantic salmon and Danube salmon, fresh/chilled Atlantic salmon, and frozen fish. Thus, the rising consumption of seafood and growing government efforts are likely to be the major factors driving the growth of the fisheries and aquaculture sector. In addition, the above-mentioned factors will fuel the aquaculture vaccines market in the forecast period.

Middle East & Africa Aquaculture Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Aquaculture Vaccines Market Segmentation

The Middle East & Africa aquaculture vaccines market is segmented into type of vaccine, species, route of administration, and country.

Based on type of vaccine the Middle East & Africa aquaculture vaccines market, is segmented into live vaccines, inactivated vaccines, other vaccines. The inactivated vaccines segment held the largest market share in in 2022.

Based on species, the Middle East & Africa aquaculture vaccines market is divided into tilapia, trout, salmon, shrimps, and others. The salmon segment held the largest share of the market in 2022.

Based on route of administration the Middle East & Africa aquaculture vaccines market, is segmented into injection vaccines, immersions vaccines, and oral vaccines. The injection vaccines segment held the largest share of the market in 2022.

Based on country, the Middle East & Africa aquaculture vaccines market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the aquaculture vaccines market share in 2022.

Elanco Animal Health Inc; HIPRA SA; Merck & Co Inc.; Phibro Animal Health Corp; and Zoetis Inc.; are the leading companies operating in the Middle East & Africa aquaculture vaccines market.